Menu

Carter Bankshares, Inc. (CARE)

$19.99
+0.02 (0.10%)
Get curated updates for this stock by email. We filter for the most important fundamentals-focused developments and send only the key news to your inbox.

Data provided by IEX. Delayed 15 minutes.

Market Cap

$453.2M

Enterprise Value

$628.7M

P/E Ratio

14.5

Div Yield

0.00%

Rev Growth YoY

+5.0%

Rev 3Y CAGR

+0.7%

Earnings YoY

+4.9%

Earnings 3Y CAGR

-8.1%

Rate Cuts Meet Rural Resilience: Carter Bankshares' Asymmetric Turnaround (NASDAQ:CARE)

Carter Bankshares operates a community banking model with 64 branches across Virginia and the Carolinas, focusing on deposit gathering and commercial/consumer lending. The bank emphasizes relationship banking, serving underserved markets with a liability-sensitive balance sheet designed to benefit from Fed rate cuts.

Executive Summary / Key Takeaways

  • Strategic Inflection at Scale: Carter Bankshares is executing a deliberate pivot from crisis management to disciplined growth, having absorbed an $85.2 million earnings hit from its 2023 credit relationship failure while simultaneously expanding into North Carolina growth markets and refreshing its brand identity—a transition that will define whether the bank compounds value or merely recovers.

  • Liability-Sensitive Leverage: With 68.6% of CDs and 77.2% of FHLB borrowings repricing within 12 months, CARE's balance sheet is engineered to capture disproportionate margin expansion as the Fed cuts rates, creating near-term earnings tailwinds that could mask underlying competitive pressures if management doesn't deploy the windfall into sustainable growth.

  • Community Banking Moat Under Siege: The bank's 64-branch network in underserved Virginia and North Carolina markets provides deposit stickiness and relationship-driven loan origination advantages, but its 0.66% ROA and 7.79% ROE lag scaled rivals like First Citizens (10.38% ROE) by 250+ basis points, revealing a scale disadvantage that technology gaps and CRE concentration risk could widen.

  • Credit Overhang Remains the Central Variable: A single $228.6 million nonaccrual relationship—still 5.4% of total loans—carries a $21.7 million specific reserve that management believes is adequate, but the collateral's concentration in hospitality, agriculture, and energy sectors means any macro deterioration could force material provision increases that derail the turnaround narrative.

  • Valuation Reflects Skepticism, Not Opportunity: At $19.95 per share, CARE trades at 14.7x earnings and 1.08x book, modest discounts to peers, but its sub-1% ROA suggests the market is pricing in persistent profitability challenges rather than rewarding the rate-cut leverage, making execution on growth and efficiency the only path to multiple expansion.

Setting the Scene: From Crisis to Calculated Expansion

Carter Bankshares, headquartered in Martinsville, Virginia since its 1974 founding, operates a straightforward community banking model: gather deposits through 64 branches across Virginia and the Carolinas, originate commercial and consumer loans, and earn spread income. This simplicity became a liability in the second quarter of 2023 when management placed its largest credit relationship—$301.9 million in commercial loans—on nonaccrual status after maturity defaults. The event didn't just create a $85.2 million cumulative earnings drag; it exposed underwriting standards that relied heavily on loan-to-value ratios without fully stress-testing borrower cash flows across speculative real estate cycles.

The bank's response reveals a management team that learned harsh lessons. In June 2023, they introduced new guiding principles with a purpose statement "To create opportunities for more people and businesses to prosper," paired with core values of "Build Relationships, Earn Trust and Take Ownership." This wasn't corporate window dressing—it was an admission that relationship banking had to mean more than personal rapport; it required disciplined underwriting guardrails. By October 2024, a new brand identity "centered entirely around the people who matter most" followed, winning national industry awards that signaled to markets the bank was shedding its staid regional image.

Strategically, CARE sits at the intersection of two powerful but opposing forces. On one side, its liability-sensitive balance sheet—68.6% of CDs and 77.2% of FHLB borrowings reprice within 12 months—positions it to capture margin expansion as the Fed implements the 100 basis points of cuts forecasted through 2026. On the other, it competes against Atlantic Union Bankshares ($24B assets) and TowneBank ($18.6B assets) in overlapping Virginia markets, both of which operate at 34-50% operating margins compared to CARE's 24%, reflecting scale economies that CARE's $4.8 billion asset base cannot replicate. The bank's expansion into Greenville, South Carolina and Winston-Salem, North Carolina growth markets, including a $55.9 million deposit acquisition from First Reliance, represents a deliberate attempt to escape this scale trap by capturing deposits in faster-growing metros where its relationship model can command premium pricing.

Technology, Products, and Strategic Differentiation

Carter Bankshares' moat isn't built on software patents or AI-driven underwriting—it's built on a relationship banking model that treats branches as community hubs rather than transaction centers. This approach creates tangible economic benefits: deposit stickiness that reduces beta-driven outflows during rate cycles, and loan origination capabilities that capture granular local data on borrower character and cash flow stability. When management enhanced underwriting standards in 2018 to consider global cash flows, speculation limits, and sensitivity analysis, they were essentially building a "soft technology" layer that larger banks' automated systems cannot replicate at the sub-$5 million loan size that constitutes CARE's bread and butter.

The brand refresh serves as a strategic differentiator in an industry where most regional banks compete solely on rate. By winning national awards for its "people-centered" identity, CARE signals to commercial clients that it offers something beyond commodity banking services. This matters because it supports pricing power—CARE can charge higher fees on treasury services and maintain loan spreads even when larger competitors undercut on price, as long as the value proposition resonates with small business owners who prioritize relationship stability over marginal rate savings.

Balance sheet management represents another underappreciated competency. The bank's decision to deploy proceeds from securities maturities and principal curtailments into higher-yielding loans rather than reinvesting in securities demonstrates active capital allocation discipline. The $300 million Pay-Fixed Swap Agreements entered in July 2024 and subsequently terminated by January 2025—while seemingly erratic—actually reflect nimble hedging of rate exposure during a period of policy uncertainty. Similarly, the $20.7 million BOLI 1035 exchange to carriers with enhanced credit ratings and better yields shows management's willingness to optimize every balance sheet line item for incremental returns.

Financial Performance & Segment Dynamics: Evidence of Inflection

The third quarter 2025 results provide the first clear evidence that CARE's strategic pivot is translating into financial momentum. Net interest income jumped 17.1% year-over-year to $33.7 million, driven by a 45 basis point decline in funding costs that flowed directly to the bottom line. This isn't just rate cycle beta—management actively repriced $1.4 billion of CDs from 4.22% to 3.50% during the nine-month period, capturing 72 basis points of savings while maintaining deposit stability. The result: net interest margin expansion that could accelerate if the Fed delivers the anticipated additional 75-100 basis points of cuts in 2026.

Loading interactive chart...

Noninterest income rose 7.4% to $17.2 million year-to-date, but the composition reveals both strength and vulnerability. A $1.9 million BOLI death benefit in Q1 provided a one-time boost, while core fee income remained flat. This matters because it shows CARE hasn't yet built sustainable non-spread revenue streams to diversify earnings, leaving it exposed to margin compression when the rate cycle eventually turns. The bank's stated goal to "increase fee income while closely monitoring operating expenses" acknowledges this gap, but execution remains unproven.

Expense control demonstrates management's operational discipline. Despite expanding into three new markets and launching a national brand campaign, noninterest expense rose only 6.0% year-to-date to $86.1 million, with salaries and employee benefits actually declining $1.3 million due to higher loan cost deferrals. This cost leverage—growing revenues 12.8% while holding expense growth to 6.0%—drove the efficiency ratio below 70% for the first time since the 2023 crisis. However, the $0.8 million increase in advertising and $0.7 million in data processing suggests CARE is investing in digital capabilities that remain nascent compared to TowneBank 's integrated insurance platform or Atlantic Union 's commercial banking tools.

Loan growth of 7.8% annualized to $210.8 million validates the expansion strategy. Commercial real estate balances increased despite the sector's well-documented headwinds, with management emphasizing that enhanced underwriting standards—global cash flow analysis, speculation limits, sensitivity modeling—are enabling them to pick up market share as larger banks retreat. The $14.6 million office loan placed on nonaccrual in Q3, secured by a northern Virginia property losing government tenants, serves as a real-time test of these new standards. The modest size (0.3% of loans) and early classification suggest the guardrails are working, but the CRE concentration at 53.8% of portfolio remains the bank's single largest risk concentration.

Outlook, Management Guidance, and Execution Risk

Management's commentary frames 2025-2026 as a transition from "restructuring the balance sheet to pursuing a prudent growth strategy." This is code for: we've cleaned up the 2023 mess and are ready to compete. The forecast that the FOMC will continue cutting rates through 2026 underpins this confidence, as each 25 basis point reduction could translate to $3-4 million in annual net interest income given the liability-sensitive position. However, this also creates execution risk—if the Fed pauses or reverses course due to inflation resurgence, the earnings tailwind becomes a headwind, and CARE lacks the diversified revenue streams of larger peers to cushion the blow.

The expansion into Greenville, South Carolina and the Gastonia loan production office represent calculated bets on Carolinas growth corridors where demographic trends outpace Virginia's stagnant population. President Brad Langs' statement about bringing "Carter Bank's relationship-driven approach" to these markets signals an intention to replicate the deposit-gathering success of the First Reliance acquisition, which captured $55.9 million in deposits at a likely cost below organic build. The risk is that these new markets lack the multi-generational customer loyalty that underpins CARE's Virginia franchise, requiring heavier marketing spend and potentially lower initial returns.

The $20 million share repurchase authorization through May 2026, of which $14.2 million was executed by September 30, suggests management believes the stock is undervalued at current multiples. However, this capital allocation choice—buying back shares rather than accelerating tech investments—reveals a conservative mindset that may underappreciate the digital transformation threat from fintech platforms and larger regional banks. The BOLI exchange and swap terminations show balance sheet sophistication, but they don't address the core strategic question: can relationship banking survive in an era where Chime and Capital One (COF) offer instant digital onboarding?

Loading interactive chart...

Risks and Asymmetries: Where the Thesis Breaks

The single large credit relationship remains the sword of Damocles over the investment case. At $228.6 million, it represents 5.4% of total loans and 55% of total nonperforming assets. Management's assertion that they are "well secured" based on discounted cash flow analysis and hospitality/agriculture collateral values requires faith in assumptions that may prove optimistic if recession hits these sectors. The specific reserve at 9.5% of principal is down from 12% at year-end, driven by $23.4 million in curtailment payments, but any deterioration could force a $10-15 million provision that would erase nearly half of annual net income.

CRE concentration risk extends beyond the legacy relationship. At 53.8% of portfolio, CARE's exposure to commercial real estate exceeds regulatory guidance and dwarfs the 35-40% typical for well-diversified regional banks. The $14.6 million office loan in northern Virginia, with government tenants vacating in Q4 2025, demonstrates how quickly seemingly stable properties can become impaired. While management argues their enhanced underwriting considers global cash flows and speculation limits, the portfolio's sheer size creates systemic risk if cap rates rise or occupancy falls broadly across Virginia and Carolinas markets.

Technology gaps represent a strategic vulnerability that could erode the deposit franchise over time. CARE's mobile and online capabilities remain basic compared to TowneBank 's integrated insurance platform or Atlantic Union 's commercial cash management tools. Younger demographics and small businesses increasingly demand 24/7 digital access, and CARE's branch-dependent model risks losing these customers to fintech platforms that offer higher deposit rates and instant loan approvals. The $0.7 million increase in data processing expense shows management recognizes the gap, but the absolute investment level remains a fraction of what scaled rivals spend on technology.

Scale disadvantage creates a permanent cost of funding penalty. With $4.2 billion in deposits versus TowneBank 's $18.6 billion and Atlantic Union 's $24 billion, CARE lacks the bargaining power to secure the lowest-cost wholesale funding or negotiate favorable vendor contracts. This shows up in the 24% operating margin versus peers' 34-50% range—a 1,000+ basis point structural disadvantage that rate cuts can temporarily mask but not eliminate. If larger competitors choose to compete aggressively on loan pricing in CARE's rural markets, the bank's cost structure may force it to choose between margin compression or market share loss.

Loading interactive chart...

Valuation Context: Pricing in Persistence, Not Potential

At $19.95 per share, Carter Bankshares trades at 14.7x trailing earnings and 1.08x book value—modest discounts to the 15.9x and 1.15x multiples of peer TowneBank , but at a significant premium to its own profitability metrics. The 7.79% ROE trails all four identified competitors, with Home Bancorp (HBCP) delivering 10.86% and First Citizens 10.38%. This valuation gap reflects market skepticism that CARE's earnings quality matches its peers, likely due to the persistent credit overhang and subscale operations.

The price-to-free-cash-flow ratio of 14.5x appears attractive relative to the 11.5x operating cash flow multiple, but this spread indicates working capital inefficiencies and reliance on non-cash adjustments that larger banks don't exhibit. More telling is the enterprise value-to-revenue multiple of 3.6x, which matches TowneBank 's 3.7x but reflects lower underlying asset quality given CARE's higher nonperforming asset ratio. The market is essentially pricing CARE as a peer-average bank while its financial metrics suggest below-average risk-adjusted returns.

Loading interactive chart...

Comparing valuation multiples to strategic positioning reveals a disconnect. Atlantic Union trades at 20.4x earnings despite slower growth because its scale enables consistent dividend payments (4.04% yield) and buybacks that CARE cannot afford. First Citizens (FCNCA)'s 12.2x multiple reflects integration risks but also the market's willingness to pay for demonstrated M&A capability. CARE's 14.7x multiple sits in no-man's-land: not cheap enough to be a deep value play, not expensive enough to reflect a true growth inflection. This suggests the stock will remain range-bound until the bank either proves it can sustain ROE improvement above 10% or suffers a credit setback that forces a repricing.

Conclusion: A Show-Me Story with Asymmetric Near-Term Upside

Carter Bankshares stands at a strategic crossroads where execution will determine whether it emerges as a durable community banking franchise or remains a subscale regional vulnerable to consolidation. The bank has successfully navigated its 2023 credit crisis, as evidenced by stabilized provision expenses, controlled cost growth, and a liability-sensitive balance sheet positioned to capture 75-100 basis points of margin expansion if the Fed delivers expected cuts. This creates an asymmetric near-term earnings setup that could drive 15-20% EPS growth in 2026 even without meaningful loan growth.

However, the central thesis hinges on whether management deploys this rate-driven windfall into sustainable competitive advantages or simply harvests short-term profits. The CRE concentration at 53.8% of portfolio and the lingering $228.6 million nonaccrual relationship represent existential risks that require both continued economic stability and management's enhanced underwriting discipline to avoid a repeat of 2023's losses. Meanwhile, technology gaps and scale disadvantages versus Atlantic Union (AUB) and TowneBank (TOWN) threaten the long-term viability of the relationship banking model that defines CARE's identity.

For investors, the critical variables to monitor are net interest margin expansion beyond 3.5% (which would validate the liability-sensitive thesis), ROE improvement above 9% (which would close the valuation gap with peers), and CRE portfolio performance (where any deterioration would expose the concentration risk). The stock's current valuation reflects market skepticism that CARE can achieve these milestones, creating potential upside if execution surprises positively—but also significant downside if the credit overhang proves larger than management anticipates. This is a show-me story where the next 12 months will determine whether Carter Bankshares becomes a compounder or a permanent laggard.

Disclaimer: This report is for informational purposes only and does not constitute financial advice, investment advice, or any other type of advice. The information provided should not be relied upon for making investment decisions. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.